← Open Payments lookup

MARY LEYDA: Open Payments

NPI 1619534146 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$754 in 36 payments from 9 companies in 2025. Trend: 2023 $1,449 · 2024 $1,114 · 2025 $754

Food & beverage: $754
CompanyPaymentsAmount
Alkermes, Inc.7$198
ABBVIE INC.8$164
Otsuka America Pharmaceutical, Inc.6$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$72
Axsome Therapeutics, Inc.3$69
Vanda Pharmaceuticals Inc.3$65
E.R. Squibb & Sons, L.L.C.3$52
Lundbeck LLC1$22
Janssen Pharmaceuticals, Inc1$15

Products named: VRAYLAR, LYBALVI, REXULTI, CAPLYTA, Auvelity, FANAPT, ARISTADA, COBENFY.

Industry payments across OR — which companies pay providers there.